Immutep Limited (IMMP:NASDAQ) closed at $3.15 on October 27, 2026, up 1.61% on the day. The stock trades 95.5% below its 52-week high of $70.60 and 3.3% above its 52-week low of $3.05. Immutep Limited is part of the Health Care sector (Major Pharmaceuticals).
In 241 trading sessions since October 27, 2025, IMMP closed higher on 82 days (34%). Its best day was April 15, 2026 (+74.19%) and its worst was March 13, 2026 (-82.61%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 2 times.
Immutep Ltd, formerly Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
Find more stocks like IMMP with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.